Prepare for your visit

Julia D Melanson

Obstetrics & Gynecology · Williamsville, NY · NPI 1982605879

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$353.81

in general payments reported to CMS, 2019-2025 · $42.94 in 2025

The $42.94 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).

Who reported paying

General payments only, top 6 by amount.

Astellas Pharma US INC $199.98
Sumitomo Pharma America, INC. $51.49
Davol INC. $26.50
Exeltis, USA INC. $16.92
Astellas Pharma Global Development $16.66
Covidien LP $15.82

Drugs and devices associated with these payments

Veozah Myfembree Gemtesa

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Julia Melanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/134805/julia-d-melanson